Press Releases

Home / Investor Relations / Press Releases

Language

Category

Year

2023-09-14 08:31 Boule signs an agreement for local instrument manufacturing in India

Boule Diagnostics has signed a licensing agreement with Q-Line Biotech for local instrument manufacturing in Uttar Pradesh, India. India is an important market with a projection of over 20,000 hematology systems to be sold each year for the next coming...

2023-07-24 07:31 Boule Diagnostics (publ) interim report April–June 2023 Regulatory

Improved gross margin Quarter April–June 2023 *A bonus issue element from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and after dilutive effects, which means that the comparative figure...

2023-07-20 15:01 Boule Diagnostics – Invitation to presentation of the interim report Q2 2023

Boule Diagnostics AB will publish the interim report for the period January–June 2023 at 07:30, Monday, July 24th, 2023. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist and CFO Jan...

2023-06-29 10:01 Boule Diagnostics today launches new veterinary 5-part hematology solution in Europe

Boule Diagnostics is today launching a new 5-part veterinary solution for cost-effective diagnostics for the European market, the H50V. It is equipped with 13 predefined animal profiles and over 30 analyzed parameters, making it a flexible system that...

2023-06-14 08:02 Boule appoints Holger Lembrér as CFO Regulatory

Boule Diagnostics AB appoints Holger Lembrér as new CFO to take office in January 2024. Holger has a long career in various senior finance positions within the ASSA ABLOY Group. He has a solid financial foundation from being CFO for a business area...

2023-05-04 18:16 Bulletin from Annual General Meeting in Boule Diagnostics AB on May 4, 2023

The Annual General Meeting 2023 (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance sheet for 2022. The AGM resolved that the company's accumulated profits shall be carried forward...

2023-05-04 09:31 Boule Diagnostics – Changes in Nomination Committee’s proposal for election of Board members 2023

The notice to Boule Diagnostics AB's annual general meeting 2023 was announced in a press release on April 4, 2023. The press release presented the nomination committee's proposal for the election of board members. The election committee has now been...

2023-05-03 07:31 Boule Diagnostics (publ) interim report January–March 2023 Regulatory

Improved gross margin Quarter January–March 2023 *A bonus issue element from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and after dilutive effects, which means that the comparative figure...

2023-04-26 15:01 Boule Diagnostics – Invitation to presentation of the interim report Q1 2023

Boule Diagnostics AB will publish the interim report for the period January–March 2023 at 07:30, Wednesday, May 3rd, 2023. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist and CFO...

2023-04-05 09:31 Boule Diagnostics publishes the annual report for 2022 Regulatory

Boule Diagnostics AB has published the full Swedish annual report for the fiscal year 2022 at http://www.boule.com. The annual report is available in Swedish below as a PDF and in the European Single Electronic Format (ESEF), printed copies of the Swedish...

2023-03-24 12:16 Nomination Committee’s proposal for election of Board members 2023

The Nomination Committee of Boule Diagnostics AB has decided to propose to the Annual General Meeting 2023 (AGM) that the number of Board members shall be six, including the Chair. The Nomination Committee proposes the re-election of Karin Dahllöf, Thomas...

2023-03-15 07:31 FUJIFILM and Boule cooperation expands into more European markets

Boule Diagnostics and FUJIFILM have expanded the strategic distributor agreement in Europe for veterinary solutions. FUJIFILM started to promote Boule product in three European countries in mid-2022. After successful results and excellent customer feedback...

2023-02-02 07:31 Boule Diagnostics (publ) Year-end report January–December 2022 Regulatory

Improved gross margin for the quarter Quarter October-December 2022 Full year January–December 2022 * A bonus issue element from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and after dilutive...

2023-01-26 15:01 Boule Diagnostics – Invitation to presentation of the year-end report 2022

Boule Diagnostics AB will publish the year-end report for the period January – December 2022 at 07:30 CET, Thursday, February 2nd, 2023. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist...

2022-12-30 15:01 Change in number of shares and votes in Boule Diagnostics Regulatory

Stockholm, Sweden, December 30, 2022 – Boule Diagnostics AB (publ) (“Boule” or the “Company”) (Nasdaq Stockholm: BOUL) has, as previously announced, carried out a preferential rights issue of shares, which has resulted in changes in the number...

2022-12-14 08:01 Boule Diagnostics appoints Jan Benjaminson as interim CFO

Boule Diagnostics AB has today appointed Jan Benjaminson as interim CFO, effective on February 3rd, 2023. Jan will succeed Annette Colin who will continue as CFO up to and including the same date. Jan has been active in several listed companies, both...

2022-11-30 08:01 Boule Diagnostics raises approximately SEK 150 million through a significantly oversubscribed rights issue Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE...

2022-11-28 07:31 Boule receives CE mark according to IVDR Class B for two product lines

Boule Medical AB has reached another important milestone in its preventive and diligent work in meeting the new and increased regulatory requirements for in vitro diagnostics. Boule has received CE mark according to IVDR class B for two of its product...

2022-11-14 15:21 Trading of subscription rights commences Tuesday 15 November

2022-11-10 14:21 Boule Diagnostics publishes prospectus in connection with its Rights Issue

Previous Next